Ebastin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ebastin" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
low place
low place
low place
6,408th place
924th place
87th place
68th place
29th place

doi.org

  • Manabu Ohyama, Atsushi Shimizu, Kyoko Tanaka, Masayuki Amagai: Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. In: Journal of Dermatological Science. Band 58, Nr. 2, Mai 2010, S. 154–157, doi:10.1016/j.jdermsci.2010.03.009, PMID 20388588.
  • Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak, Martin Storr, Jakub Fichna: Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. In: Journal of Neurogastroenterology and Motility. Band 23, Nr. 3, 30. Juli 2017, S. 341–348, doi:10.5056/jnm16203, PMID 28551943, PMC 5503283 (freier Volltext).
  • Anne-Marie Ellegaard, Christian Dehlendorff, Anna C. Vind, Atul Anand, Luise Cederkvist: Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. In: EBioMedicine. Band 9, Juli 2016, S. 130–139, doi:10.1016/j.ebiom.2016.06.013, PMID 27333030, PMC 4972561 (freier Volltext).
  • J Sastre: Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. In: Journal of Investigational Allergology and Clinical Immunology. Band 30, Nr. 3, 18. Juni 2020, S. 156–168, doi:10.18176/jiaci.0401 (jiaci.org [PDF]).
  • Tatsuya Isomura, Takeshi Kono, Ian Hindmarch, Norimasa Kikuchi, Aya Murakami: Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-. In: PLoS ONE. Band 9, Nr. 12, 12. Dezember 2014, doi:10.1371/journal.pone.0114336, PMID 25501360, PMC 4264760 (freier Volltext).
  • M. Nori, S. Iwata, Y. Munakata, H. Kobayashi, S. Kobayashi: Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines. In: Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. Band 33, Nr. 11, November 2003, S. 1544–1554, doi:10.1046/j.1365-2222.2003.01701.x, PMID 14616867.

europa.eu

echa.europa.eu

jiaci.org

  • J Sastre: Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. In: Journal of Investigational Allergology and Clinical Immunology. Band 30, Nr. 3, 18. Juni 2020, S. 156–168, doi:10.18176/jiaci.0401 (jiaci.org [PDF]).
  • A. del Cuvillo, J. Mullol, J. Bartra, I. Dávila, I. Jáuregui: Comparative pharmacology of the H1 antihistamines. In: Journal of Investigational Allergology & Clinical Immunology. 16 Suppl 1, 2006, S. 3–12, PMID 17357372 (jiaci.org [PDF]).

nih.gov

ncbi.nlm.nih.gov

  • Manabu Ohyama, Atsushi Shimizu, Kyoko Tanaka, Masayuki Amagai: Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. In: Journal of Dermatological Science. Band 58, Nr. 2, Mai 2010, S. 154–157, doi:10.1016/j.jdermsci.2010.03.009, PMID 20388588.
  • Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak, Martin Storr, Jakub Fichna: Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. In: Journal of Neurogastroenterology and Motility. Band 23, Nr. 3, 30. Juli 2017, S. 341–348, doi:10.5056/jnm16203, PMID 28551943, PMC 5503283 (freier Volltext).
  • Anne-Marie Ellegaard, Christian Dehlendorff, Anna C. Vind, Atul Anand, Luise Cederkvist: Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. In: EBioMedicine. Band 9, Juli 2016, S. 130–139, doi:10.1016/j.ebiom.2016.06.013, PMID 27333030, PMC 4972561 (freier Volltext).
  • Tatsuya Isomura, Takeshi Kono, Ian Hindmarch, Norimasa Kikuchi, Aya Murakami: Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-. In: PLoS ONE. Band 9, Nr. 12, 12. Dezember 2014, doi:10.1371/journal.pone.0114336, PMID 25501360, PMC 4264760 (freier Volltext).
  • A. del Cuvillo, J. Mullol, J. Bartra, I. Dávila, I. Jáuregui: Comparative pharmacology of the H1 antihistamines. In: Journal of Investigational Allergology & Clinical Immunology. 16 Suppl 1, 2006, S. 3–12, PMID 17357372 (jiaci.org [PDF]).
  • M. Nori, S. Iwata, Y. Munakata, H. Kobayashi, S. Kobayashi: Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines. In: Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. Band 33, Nr. 11, November 2003, S. 1544–1554, doi:10.1046/j.1365-2222.2003.01701.x, PMID 14616867.

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

sigmaaldrich.com

tcichemicals.com